GoodRx Holdings, Inc. (GDRX)
GDRX Stock Price Chart
Explore GoodRx Holdings, Inc. interactive price chart. Choose custom timeframes to analyze GDRX price movements and trends.
GDRX Company Profile
Discover essential business fundamentals and corporate details for GoodRx Holdings, Inc. (GDRX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
23 Sept 2020
Employees
738.00
Website
https://www.goodrx.comCEO
Wendy Barnes
Description
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.
GDRX Financial Timeline
Browse a chronological timeline of GoodRx Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 25 Feb 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is $0.09, while revenue estimate is $195.17M.
Earnings released on 6 Aug 2025
EPS came in at $0.09 falling short of the estimated $0.10 by -10.00%, while revenue for the quarter reached $203.07M , missing expectations by -1.06%.
Earnings released on 7 May 2025
EPS came in at $0.09 matching the estimated $0.09, while revenue for the quarter reached $202.97M , beating expectations by +0.38%.
Earnings released on 27 Feb 2025
EPS came in at $0.09 falling short of the estimated $0.10 by -10.00%, while revenue for the quarter reached $198.58M , missing expectations by -0.58%.
Earnings released on 7 Nov 2024
EPS came in at $0.08 falling short of the estimated $0.09 by -11.11%, while revenue for the quarter reached $195.25M , missing expectations by -2.49%.
Earnings released on 8 Aug 2024
EPS came in at $0.08 falling short of the estimated $0.09 by -11.11%, while revenue for the quarter reached $200.61M , beating expectations by +0.08%.
Earnings released on 9 May 2024
EPS came in at $0.08 falling short of the estimated $0.09 by -11.11%, while revenue for the quarter reached $197.88M , missing expectations by -1.30%.
Earnings released on 29 Feb 2024
EPS came in at $0.08 matching the estimated $0.08, while revenue for the quarter reached $196.64M , beating expectations by +0.42%.
Earnings released on 9 Nov 2023
EPS came in at $0.06 matching the estimated $0.06, while revenue for the quarter reached $179.96M , missing expectations by -5.68%.
Earnings released on 9 Aug 2023
EPS came in at $0.07 surpassing the estimated $0.06 by +16.67%, while revenue for the quarter reached $189.68M , beating expectations by +1.53%.
Earnings released on 10 May 2023
EPS came in at $0.07 surpassing the estimated $0.06 by +16.67%, while revenue for the quarter reached $183.99M , beating expectations by +1.05%.
Earnings released on 28 Feb 2023
EPS came in at $0.07 surpassing the estimated $0.05 by +40.00%, while revenue for the quarter reached $184.11M , beating expectations by +3.14%.
Earnings released on 8 Nov 2022
EPS came in at $0.07 surpassing the estimated $0.04 by +72.58%, while revenue for the quarter reached $187.32M , beating expectations by +1.23%.
Earnings released on 8 Aug 2022
EPS came in at $0.06 surpassing the estimated $0.04 by +54.36%, while revenue for the quarter reached $191.80M , beating expectations by +3.84%.
Earnings released on 9 May 2022
EPS came in at $0.10 surpassing the estimated $0.08 by +25.00%, while revenue for the quarter reached $203.33M , beating expectations by +1.43%.
Earnings released on 28 Feb 2022
EPS came in at $0.09 falling short of the estimated $0.10 by -10.00%, while revenue for the quarter reached $213.26M , missing expectations by -1.93%.
Earnings released on 10 Nov 2021
EPS came in at $0.09 surpassing the estimated $0.08 by +12.50%, while revenue for the quarter reached $195.10M , missing expectations by -62.96%.
Earnings released on 12 Aug 2021
EPS came in at $0.08 matching the estimated $0.08, while revenue for the quarter reached $176.64M , meeting expectations.
Earnings released on 13 May 2021
EPS came in at $0.07 falling short of the estimated $0.08 by -12.50%, while revenue for the quarter reached $160.43M , meeting expectations.
Earnings released on 11 Mar 2021
EPS came in at $0.08 surpassing the estimated $0.06 by +33.33%, while revenue for the quarter reached $153.54M .
Earnings released on 12 Nov 2020
EPS came in at $0.09 surpassing the estimated $0.08 by +12.50%, while revenue for the quarter reached $140.45M , beating expectations by +14.29%.
GDRX Stock Performance
Access detailed GDRX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.